Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 4 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
tisocki k
(20 results)?
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21.
J Clin Oncol. 2024.
PMID: 37864337
Free PMC article.
Clinical Trial.
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Pant S, Schuler M, Iyer G, Witt O, Doi T, Qin S, Tabernero J, Reardon DA, Massard C, Minchom A, Lugowska I, Carranza O, Arnold D, Gutierrez M, Winter H, Stuyckens K, Crow L, Najmi S, Hammond C, Thomas S, Santiago-Walker A, Triantos S, Sweiti H, Loriot Y; RAGNAR Investigators.
Pant S, et al.
Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9.
Lancet Oncol. 2023.
PMID: 37541273
Clinical Trial.
Item in Clipboard
Anthracyclines in the treatment of early breast cancer friend or foe?
Vuger AT, Tiscoski K, Apolinario T, Cardoso F.
Vuger AT, et al. Among authors: tiscoski k.
Breast. 2022 Oct;65:67-76. doi: 10.1016/j.breast.2022.06.007. Epub 2022 Jul 7.
Breast. 2022.
PMID: 35839583
Free PMC article.
Review.
Item in Clipboard
Real-world data on triple-negative breast cancer in Latin America and the Caribbean.
Tiscoski KA, Giacomazzi J, Rocha MS, Gössling G, Werutsky G.
Tiscoski KA, et al.
Ecancermedicalscience. 2023 Nov 21;17:1635. doi: 10.3332/ecancer.2023.1635. eCollection 2023.
Ecancermedicalscience. 2023.
PMID: 38414969
Free PMC article.
Review.
Item in Clipboard
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators.
Martín M, et al.
J Clin Oncol. 2024 Mar 27:JCO2301500. doi: 10.1200/JCO.23.01500. Online ahead of print.
J Clin Oncol. 2024.
PMID: 38537155
Item in Clipboard
Effectiveness of adjuvant trastuzumab in women with HER-2+ breast cancer in the SUS.
Batista JDL, Alves RJV, Cardoso TB, Moreno M, Tiscoski KA, Polanczyk CA.
Batista JDL, et al. Among authors: tiscoski ka.
Cien Saude Colet. 2023 Jun;28(6):1819-1830. doi: 10.1590/1413-81232023286.15092022. Epub 2022 Nov 6.
Cien Saude Colet. 2023.
PMID: 37255158
Free article.
English, Portuguese.
Item in Clipboard
The cost of metastatic prostate cancer using time-driven activity-based costing.
Vargas Alves RJ, Beck da Silva Etges AP, Tiscoski KA, de Lara LR, de Medeiros Zelmanowicz A, Polanczyk CA.
Vargas Alves RJ, et al. Among authors: tiscoski ka.
Int J Technol Assess Health Care. 2021 Apr 26;37(1):e60. doi: 10.1017/S0266462321000271.
Int J Technol Assess Health Care. 2021.
PMID: 33896428
Item in Clipboard
Cite
Cite